Ignite Creation Date:
2025-12-26 @ 4:01 PM
Ignite Modification Date:
2025-12-26 @ 4:01 PM
Study NCT ID:
NCT04652206
Status:
UNKNOWN
Last Update Posted:
2021-12-29
First Post:
2020-11-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients.
Sponsor:
Scandion Oncology A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-05-15
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-20
First Submit QC Date:
None
Study First Post Date:
2020-12-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-28
Last Update Post Date:
2021-12-29
Last Update Post Date Type:
ACTUAL